White Paper C e l l p i n d a T o k e n

Security Token Offering

2018 © Cellpinda Co., Ltd. All rights reserved

English Version

--------------------------------------------------------------------------------- 4

-------------------------------------------------------------------------- 6

-------------------------------------------------------------------- 7

------------------------------------------------------------------------- 11

------------------------------------------------- 11

---------------------------------------- 12

----------------------------------------------- 14

-------------------------------------------- 14

------------------------------------ 15

------------------------------------------- 15

-------------------------------- 16

---------------------------------------------------------------------- 16

------------------------------------------------------------- 17

------------------------------------------------------ 19

--------------------------------------------------------- 21

----------------------------------------------------------------- 22

----------------------------------------------------------------------- 23

--------------------------------------------------------------------- 24

------------------------------------------------------------ 26

-------------------------------------------------------- 27

----------------------------------------------- 28

------------------------------------------------------------------------ 29

----------------------------------------------------------------------- 30

Contents

1. Abstract

2. Cellpinda

2.1 Overview

2.2 Core Competencies & Strengths

2.3 Brands

2.3.1 Hangover Cure, S’tei

2.3.2 Brain Amino acid, GABA100

2.3.3 Products to Be Launched

2.3.4 Product Development Plan

2.4 Product Distribution

2.4.1 Product Distribution in the Korea

2.4.2 Global Product Distribution

2.4.3 Cell’in(Authorized Seller & Investor )

2.5 Target Sales

2.6 Business Roadmap

3. Cellpinda Token

3.1 Security Token Offering

3.2 Dividend & Benefit

3.3 Token Economy

3.4 Eco-system

3.5 Cellpinda App

3.6 Cellpinda Online mall

3.7 Cellpinda Token Wallet

3.8 Token Sales Reporting System

3.9 Blockchain

3.10 Distribution

4. Policy

4.1 Risk and Uncertainty

4.2 STO Participants

4.3 Usage of Token

4.4 Cancellation and Refunds

4.5 Withdrawal limit

4.6 Lock-Up

5. Team & Advisor

5.1 Team

5.2 Advisor

----------------------------------------------------------- 31

--------------------------------------------------------------- 31

------------------------------------------------------------------ 31

---------------------------------------------------- 31

----------------------------------------------------------------- 31

-------------------------------------------------------------------------- 31

------------------------------------------------------------------------------ 32

-------------------------------------------------------------------------- 33

1. Abstract

According to a report by ICO analyst ICODATA.IO, the total size of ICO in

2017 was 6.1 billion dollars. But according to cryptocurrency media

Bitcoin.com, the failure rate of the last year was 59%, 142 of total 902 ICO

failed to raise funds, 276 failed after raising funds, and 113 businesses of the

rest were categorized to have almost no possibility of succeeding their

proposed projects.

The reason the failure rate of the existing ICOs were high is analyzed to be the

result of investing to corporates with Business Concept as the major standard

of decision. Whether the business will succeed or fail can be judged by the

references of the corporate, such as practical experiences and market

experiences, where as the previous ICOs were proposed with impractical

theoretical concepts. In addition, the roles of advisors were limited to gaining

trust from the market rather than practical communications on advancing the

business, and the act using their name were paid as coins which exhausted the

business fund.

Another problem of ICO is that the investors cannot demand the business

profit of the issuing company. Publicized coins only functioned as payment

options, thus only the raise of the value and arbitrage trading were expected,

and the purpose of speculation grew.

To eradicate the evil of the abovementioned ills of ICO, Security Token

Offering was proposed as an alternative, which is a method of issuing

cryptocurrency based on actual commercialized business and distributing

business profit to token holders. USA’s Securities and Exchange Commission

also appreciate STO as marketable securities under certain circumstances.

These circumstances are ‘if there is business with actual sales’ and ‘if the issuer

can distribute business profit to investors.’

Cellpinda is Bioproduct manufacturing and distributing company with actual

sales, and Cellpinda issued STO where the token holders can receive the profit

of the business. Thus Cellpinda satisfies the conditions of STO and the demand

of the society that wishes to eliminate the illness of ICO, thus having significant

financial and social meaning. Also, with fund raised by selling issued Cellpinda

Tokens, Cellpinda wishes to lead rational investment culture by advancing to

global market and diversifying the distribution channels for achieving eye-

opening sales growth and offering business profit to the investors.

4

2. Cellpinda 2.1 Overview

Cellpinda Co., Ltd., is a biofood manufacturing and distributing corporate, a

health function food company that strives Stress-free lives for customers. The

major industrial area is biofunction foods to escape daily life stresses such as

stress, hangover, sleep disorders, sexual dysfunctions, etc. and biofoods to

treat metabolic syndromes called as habit diseases, such as blood pressure

disorders, diabetes, etc. and chronic diseases.

Cellpinda entered the health function food market with hangover cure S’tei,

which Cellpinda started to deliver to Jeil Pharmaceutical Co., Ltd., since 2016.

It began distributing S’tei with company name ‘Free-B Lab,’ and in 2018,

it changed its name to Cellpinda and established a corporation.

Cellpinda’s management philosophy is ‘Take action & Prove it’, and the

corporate’s mission is ‘Creating the value of happiness of humanities’ body and

heart.’ Moreover, Cellpinda suggests a vision of ‘Growing into a bio company

that the whole world watches by proposing a new paradigm of biosimilar.’

*Biosimilar: generic drugs having similar medical effect to high-price original

biomedicines supplied at lower price.

Cellpinda’s management principle is: firstly, creating the real value; secondly,

symbiosis and transparent management’; thirdly, ‘challenge and spirit’; and

fifthly, ‘leading the world.’ Thus Cellpinda ‘established global distribution and

product diversification as its business strategy,’ and established a long-term

business plan as growing into a global biofood company/pharmaceutical

corporate with continuous R&D.

Step 3. 2018

Develop GABA,

ornithine, and other

biosimilar foods.

Step 2

Secure original

technology and

build raw material

manufacturing/distri

bution infrastructure

Step 1

Grow into a global

biofood company

Step 4. 2020

6

Completed building

own online store,

diversify national

sales channel,

prepare global

distribution hubs

& diversify products.

2.2 Core Competencies & Strengths 2.2.1 Core Competencies

Unlike Cellpinda’s previous ICO, Cellpinda is a corporate with sales achieving a

stable sales growth. It is distributing hangover cure product S’tei to about

4,000 pharmacies in South Korea by delivering the product to Jeil

Pharmaceutical. In June, Cellpinda ordered manufacture of 5,000 boxes of S’tei

to sell them on the main company, and the supply contract with Jeil

Pharmaceutical was 30,000 boxes as first delivery, and another 30,000 boxes

as the second, which increased the sales of the second half of 2018 to be 12

times than the sales in the first half.

Cellpinda is a leading company that applied enzyme technology-based

biosimilar to health function food, and became competitive in the market with

the following competencies.

(1) Biosimilar

(2) Global quality certification

(3) Global Distribution Network

(4) Cell’in(Authorized Seller)

Cellpinda owns 11 patents of enzyme technology based raw

material cultivation and extracts technology, such as GABA,

ornithine, alanine, etc.

Cell’in means ‘Cellpinda In(人: Chinese letter for person),’ and

refers to authorized sellers of Cellpinda products. Cell’ins are

the business agents who can benefit from selling Cellpinda

products and gain the distribution of business profits, and are

the core members who improves the enterprise value.

Global on/offline distribution network even to the outside of Asia.

▶ Owns distribution network of Korean and global major online commerce

▶ Various sales channel distribution to pharmacies, convenient stores, home

shopping, large stores, etc

Worldly recognized HALAR certification, KOSHE certification,

from ISO22000 to HACCP certification verifies Cellpinda’s

safe raw material procession and quality.

7

[certification list]

[patent list]

Patent number Contents

10-0589121 Method for the Manufacture of L-Ornithine by Enzyme Reaction

10-0903690 Composites and Alcoholic Drinks for Hangover Cures

10-0857215 Method for the Manufacture of High-purity GABA by using Enzyme

10-1298111 Method for the Manufacture of GABA-enhanced Rice Bran Extract Water

10-1740968 Method for the Manufacture of GABA From Lactic Acid Bacteria by Fed-Batch Supply of L-Glueta

mic Acid

10-1764124 Method for the Manufacture of D-Alanine by Fed-Batch Supply of Aspartic Acid

10-1806873 Method for the Manufacture of D-Alanine by Fusion Enzymes

10-1841553 Composites for Sexual Function Enhancement containing Ornithine or Ornithine Salts

10-0631857 Lactobacillus Brevis OPK-3, GABA producing strain

10-0675955 Glutamate Decarboxylase Gene separated from lactic acid bacteria, Lactobacillus Brevis OPK-3

10-1742477 Method for Gradually Producing D-Theronine and Homoallanine From Racemic Threonine

[HALAL] [KOSHER] [ISO22000] [HACCP]

Halal is a certificate based

on Islamic law. It is one of

the four global certificates,

that appreciates the

certificated food as ‘foods

being praised to the god.’

The certificated foods are

reexamined every 2~3

years, and preferred

by Muslims, 25% of the

world population.

Kosher is a certificate

based on Jewish law, and

is one of the four global

certificates that has 168

strict clauses. Preferred by

North Americans and

Europeans whom are

interested in health and

environment-friendly

items.

ISO22000 is an

internationally common

certificate set by

International Organization

for Standardization(ISO),

and it guarantees the

quality of the overall safety

and management system.

The second candidate to

receive the certificate (as

food additives; the

certificate recommended

by international institutes

like WHO, Codex, FAO,

and advancing countries

like EU, USA, Japan,

South Korea, etc.

8

2.2 Core Competencies & Strengths 2.2.2 Strengths (1) Biosimilar Applied Health Function Food

Cellpinda’s method for Biosimilar application is applying enzyme technology

on health function foods.

Its strength is on having similar effect to the medicines while not having the

side effects and addictive elements of the medicines.

Also, as it is health function food, it has great market accessibility as the

customers may easily buy the products from ordinary markets like online stores,

large stores, convenience stores, pharmacies, etc. unlike how the medicines

needs to be prescribed.

9

(3) Pure GABA & R&D Skills

Cellpinda can produce high-purity GABA with abovementioned patent

‘Method for the Manufacture of High-purity GABA by using Enzyme’ (No:10-

0857215) and own manufacturing process design. Cellpinda is the only one in

South Korea that can produce 100% pure GABA extracted from natural lactic

acid bacteria, and chemical GABA in overseas market is usually cheap products

made in China. In relation to the quality, Cellpinda’s GABA is examined to be

the best in the world, being about 10 years ahead than Germany’s similar

technology. Moreover, Cellpinda is carrying enzyme technology research works

and continuously submitting patent applications every year, while carrying out

various R&D of products

*GABA: Also known as Brain Food, GABA is an abbreviation of Gamma-Amino Butyric Acid, and it is a

type of amino acid. By controlling the overall excitability of nerve cells, it has an important role in normal

function of the brain. GABA is effective at : improving blood stream in the brain; increase oxygen supply;

nerve calming effect by improving metabolism of brain cells; relieving stress; improve memory; stimulate

secretion of growth hormone; hypotensive effect; relieving depression; preventing stroke and dementia;

treating sleep disorder, obesity, hyperlipidemia, anxiety disorders, menopausal disorder, etc., and

recently it was discovered that it has metastasis suppressing effect and genesistasis effect of cerebral

apoplexy, colon cancer and colorectal cancer cells. In fact, GABA is used as medicine to improve brain

metabolism in Japan.

Sources 1: Generation and usage of GABA _ Taejin Gang, Sukhong Oh, Department of Food and

Biotechnology, Woosuk University, 2: Explanation of Functions of GABA and the Possibility of

Developing New Material, 3 : Naver Encyclopedia / Korea Society for Molecular and Cellular Biology, 4.

Japan’s 協和醱酵工業

[Raw Material Supply and R&D Center]

10

2.3 Brands

Cellpinda has other products than hangover cure S’tei currently being sold in

the market total of 7 brand products: brain health food and stress reliever

GABA100 being prepared to be launched in 2018; Sleeping Disorder

Treatment Sweet Dream (temporal name) which the clinic trial is finished; Inner

beauty product I•B, the eating cosmetic; ONKI (temporal name) for blood

stream improvement; and energy drink Ready Bear; Cellpinda aims at

increasing the market share of the products each category of the market it is in.

11

2.3.1 Hangover Cure, S’tei

The Korea hangover cure market is showing higher growth rate than the

growth rate of the size of liquor market. Liquor Market achieved 2.7% growth

of size to 6 trillion 120 billion won liquor market in 2016 from 2015, but the

hangover cure market showed a growth of 15.1% from 135.3 billion won in

2015 to 155.7 billion won in 2016.

The reason for this growth is analyzed to be the demand of young adults with

age of 20s and 30s, and people tended to seek for hangover cure even if they

drank lightly. According to AC Nielsen, the total market size of hangover cure

products in 2016 was 180 billion won, and expected it to grow to 200 billion

won by 2017.

The hangover cure market showed high market share of drinks, and recently

the hangover cure pills appeared to the market. It is seemed that being easy to

take and psychological factor of taking pill being effective on curing hangover

appealed to the market. Samyang Also introduced a pill product, and revealed

that the sales has increased three times compared to the previous year.

[Source] http://news.donga.com cited article titled ‘Hangover Cures are More Popular than Liquors’

Hangover Cure S’tei is a product that used ornithine as its base, which is also

contained in freshwater clams Koreans traditionally used as base of hangover

cure soup, and is taken before and after drinking. It was released to the market

with the name of Jeil Phamaceutical and Jeil Health Science, and currently sold

in the name of Cellpinda as well. S’tei, currently being sold to about 4,000

pharmacies in South Korea, is the popular product the customers who

experienced its effect come back for and became famous. Continuous supply

contracts are made, and is planned to be sold in 10,000 pharmacies in South

Korea. Moreover, it is sold on Cellpinda’s online store, social commerce, online

open markets, and aims to reach 4 billion won per year, which is 2% of the

hangover cure market.

12

[Hangover Cure , S’tei ]

2.3.2 Brain Amino acid, GABA100

Above mentioned GABA helps brain to function normally by improving

bloodstream in brain, increase oxygen supply, and improving metabolism of

the brain cell. As the brain functions normally, the overall health stabilizes via:

acceleration of secretion of growth hormones; memory improvement;

concentration improvement; relieving stress; treating blood pressure/diabetes;

treating diabetes, hyperlipidemia, sleeping disorders, anxiety disorders, and

menopausal disorders; preventing stroke and dementia; and suppressing

metastasis of cerebral apoplexy, colon cancer and colorectal cancer cells.

Thus GABA is categorized into Brain Health Market as well as market for infant

and children growth, students and test takers who needs academic ability,

stress reliever for office workers and business men, treatment for chronic

diseases like diabetes, blood pressure disorders, etc. and metabolism

improvements, and sleeping, anxiety, panic disorders; it is the most

representative product in the brain health market thus having astronomical

value in the global market standards.

13

[Cellpinda ‘S Brain Aminoacid, GABA100 ]

According to Korea Institute of Science & Technology Evaluation and Planning,

the size of brain industry is 204 trillion won, the size of cerebral medicine

market is 170 trillion won, and its growth rate until 2020 is 5% per year, and if

the brain health function food market size is expected to be 1% of the 170

trillion won cerebral medicine market, which is 1.7 trillion won, thus brain

health related market is analyzed as the global blue ocean.

[Source] Joongang Megazine ‘A Long Road Ahead for Brain Industry Promotion] ICT Corporates need to

invest more on brain researches’ Aurhtor: Seungjun Yoo_Cheif of Korea Bio-Economy Research Center

Due to busy city life of 21st century, exposure to massive media, extreme

individualization, etc., stress and anxiety disorders are becoming more frequent,

and the number of mental disorders and opportunist crimes are increasing. This

resulted in high individuals and customers’ demand of brain health and stability,

thus the market demand for GABA is expected to be very high.

GABA related medicines and health function foods are already being sold in

overseas markets, GABA rice or GABA brown rice are becoming popular in the

Korean Market, and there is even GABA chocolate.

The effect of GABA and GABA products are well-known through the exposure

to the market and media, being appreciated by the global customers; the

market entry of GABA100 is expected to be simple and easy.

14

2.3.3 Products to Be Launched

(1) Sleeping Disorder Improver ‘Sweet Dreams’(Temporal name)

According to SK Corp., the global sleeping disorder-related medicine market

is 3 billion dollars. Cellpinda expects 1% of 3 billion dollar market, 30 million

dollars to be replaced by health function food; the clinic trial ended in 2018,

and it will be released by the first half of 2019.

(2) Sexual Health Product ‘XL’(Temporal Name)

According to the data by Sandoz, the multinational pharmaceutical, the size

of the drugs for erectile dysfunction market is 1 billion 7 thousand dollars.

Cellpinda set the market goal of XL as 11 billion won, the 1% of the market

size. The clinic trial of XL has ended, and is planned to be released by the first

half of 2019.

2.3.4 Product Development Plan

(1) GABA Drinks (GABA water, coffee, lactic acid bacteria)

Cellpinda is currently developing GABA Water for easier consumption of

GABA, intestinal health function product GABA Lactic Acid Bacteria, and GABA

Coffee; the launch of the offline store for drinks, Cellpinda Café is under

process.

(2) GABA Supplement Medicine

GABA is used as medicine in various fields via the principal of concentration

control within body. In fact, the medicine called Phenibut is a chemical material

similar to GABA and it is used for improving anxiety, fear, sleeping disorder,

nervousness, stress, fatigue, PTSD, depression, alcohol addiction and irregular

heartbeat, memory, learning, and thinking

[Source] https://www.webmd.com This shows that GABA has great potential as medicine;

Cellpinda will prepare various affairs such as product development and clinic

trials, to manufacture GABA-based medicines and medical supplies.

15

2.4 Product Distribution 2.4.1 Product Distribution in the Korea

The distribution of Cellpinda products in South Korea are done both in online

and offline circumstances: the offline distribution consists of pharmacies, large

stores like E-mart, Homeplus, etc., convenience stores like CU, Seven Eleven,

etc. Shop-in-shop of coffee brands like Starbucks, etc., and Cellpinda Café

(Direct Store under Cellpinda); and online distribution consists of Online

commerce like Coupang, Tmon, online open markets like G-market, Auction,

etc., 5 major home shopping – Lotte/GS/CJ/Hyundai/NS, & own Online store.

2.4.2 Global Product Distribution

Global distribution would be made firstly to USA, China, Thailand, Philippines,

where the market appeal of S’Tei and GABA100 is easy, and by building

product manufactures and distribution hubs on the listed companies to enter

global market with fast product supply. The second global market extension

would be to Germany and Japan, where the GABA market is already

established.

Similar to online distribution in South Korea, Products will be sold on online

stores like eBay, Amazon, etc., and the English service of Cellpinda Online Store

will be proceeded. The global offline distribution will begin with distribution of

products via large retailer stores such as Walmart, Target, etc. The overseas

offline distribution will begin with affiliation with sourcing agency, and then

gradually shift to direct sourcing.

16

Offline ▶

Online ▶

DrugStore Mart Shop In Shop CVS Cafe

Online Mall

Social Commerce

Home shopping

Open Market

2.4.3 Cell’in (Authorized Seller & Investor)

Cell’in refers to an authorized seller that can sell Cellpinda’s products, and

Cellpinda grants agency rights and qualification to Cell’ins. A similar business

model would be ‘cody’ of Woongjin Coway. Codies sold Woongjin Coway’s

various products via direct consultation with customers. This was directly

related to the sales of the business and the enterprise, raising the enterprise

value of Woongjin Coway by several tens of percent in the enterprise value

evaluation.

The premium for being a Cell’in, the agent businessperson of Cellpinda, is 5.5

million won(KRW) or 400 thousand Cellpinda Tokens. Cellpinda guarantees

40% of product sales profit to Cell’in, and if Cell’in owns more than 400

thousand Cellpinda Tokens, they are granted with rights to receive distribution

of 20% of the overall business profit.

2.5 Sales Goal

The sales goal of Cellpinda for 2019 is total at 20 billion won by the home

market of hangover cure S’tei, brain health product GABA100, sleeping

disorder improver Sleep Tight, and sexual improver XL, and we expect sales

growth of over 5 times via entry of markets of China, Japan, USA, and South

East Asia.

Brand Distribution channel Sales goal

S’tei Online Commerce, Open Market, CVS 2000000000

KRW

GABA100 Online Commerce, Cellpinda App, Home Shopping, Visit Sale

12000000000 KRW

Sweet Dream Online Commerce, Open Market, CVS, Visit Sale

5000000000 KRW

XL Online Commerce, Open Market, CVS Cellpinda App, Home Shopping, Visit

3000000000 KRW

SUM 22000000000

KRW(Yearly)

17

2.6 Business Roadmap

2018. 10

2018.12

2019.01

2019.02

- Issuance of Cellpinda Token and beginning of the sales

- Renewal of Cellpinda Token website and Official Cellpinda Corporate

Website.

- Release of Stress Reliever GABA100

- Beginning of Door-to-Door sales and Online Store Marketing of GABA100

- Beginning of sales of S’tei on online commerce and open markets

- Sales of GABA100, on home shopping

- Launching of 5 Cellpinda products: sexual health product, sleeping

disorder improvement product, energy drink, inner beauty product, and

cold feet and hands/bloodstream improvement product.

- Mainnet Review and Technology White Paper Update

- Beginning sales of 5 brand product, sexual health product, sleeping

disorder improvement product, energy drink, inner beauty product, and

cold feet and hands/bloodstream improvement product, to existing

sales channels: door-to-door sales, home shopping, online commerce,

open market.

2019.03

2019.04

2019.06~12

- Review of countries to have Security Token Offering revealed.

- Affiliated with overseas product manufacturing factory and

distribution hubs on USA, Germany, Philippines, Thailand, and China

- Launched GABA100, stress reliever to overseas market, launching

GABA100 Water

- Delivering to overseas drink manufacturer, large online commerce,

large offline distribution stores

- Launched Cellpinda Online Store globally & Cellpinda Café

- Expected to be listed on domestic and overseas cryptocurrency exchanges

- Begin development of Cellpinda GABA supplying medicine

18

C e l l p i n d a T o k e n

Security Token Offering

3. Cellpinda Token 3.1 Security Token Offering

3.1.1 Background

Previously issued utility tokens by ICO (Initial Coin Offering) had rights to

purchase products and services of the company, but the holders couldn’t

demand for the business profit. Security Token Offering (STO) was suggested

as the alternative method for remedying the disadvantage of ICO.

STO’s security tokens functions similar to securities, thus the token holders can

receive distribution of the profit the company gained. USA’s NASDAQ is known

to be developing a platform for STO, and Bithumb, the representative

cryptocurrency exchange of South Korea is cooperating with seriesOne of USA

to establish a Securities Token Exchange; STO is expected to replace ICO.

3.1.2 Purpose

STO requires a consideration of investors and clients’ demand of the payment

function for purchasing the products the company offers. Thus Cellpinda issued

Cellpinda Token, the security token where the holders can receive the

distribution of business profit that also has function of utility tokens that allows

to be exchanged for points to purchase products when needed. Its purpose is

also on raising funds for distribution channel diversification, global market

entry, and product diversification research.

20

3.1.3 Feature

Cellpinda Token is fundamentally Security Token, which means a portion

business profit is distributed to the token holders, and owned tokens can be

exchanged for points at Cellpinda Wallet to use it as a payment option for

purchasing products.

The exchange rate of Cellpinda Token for Cellpinda Points is

[Number of Tokens] × [Points], and we plan to increase the exchange value in

phase by increasing the number of points by multipliers. The increase of

exchange rate for points is applied after being listed on the exchange and the

increase rate of exchange rate is always notified on the corporate website or

Cellpinda Token website.

[ Exchange Rate of Cellpinda Token to Points ]

Cellpinda Token Point The Value of

Exchanging for Real Product

× =

400,000 EA 5 Point 2,000,000 Point × =

21

Cellpinda Wallet Payment Dividend

Point Token Conversion

3.2 Dividend & Benefit

Cellpinda distributes business profit to Cellpinda Token owning investors.

The distribution is made every quarter of year beginning from 2018 Q4, and

the amount of distribution is based on the grade determined by the amount of

tokens owned. 20% of the business profit is distributed to token holders with

400 thousand Cellpinda Tokens or more, and the amount of distribution is

differentiated by every 400 thousand tokens. 10% of the business profit is

allocated for token holders less than 400 thousand Cellpinda Tokens, and the

amount of distribution is differentiated by every 40 thousand tokens.

The unit(level) is determined by the floor of the amount of tokens owned with

standard of the applied width, and the token holders may buy more tokens to

increase the distribution unit(level) before the distribution qualification

examination period. The subjects of distribution are limited to the investors

who purchased the tokens before the token being listed on the cryptocurrency

exchange.

EA 40000 80000 120000 160000 200000 240000 280000 320000 360000

Benefit 10% of operating profit is allocated to dividends

22

EA 400000 800000 1200000 1600000 2000000 …

Benefit 20% of operating profit is allocated to dividends

[Dividend (Holds less than 400,000) ]

[Dividend (Holds Over than 400,000) ]

3.3 Token Economy

Cellpinda Tokens can be traded only after it is listed on the cryptocurrency

exchanges, and owned tokens may be exchanged for points to purchase

various products from Cellpinda online store. Cellpinda distributes the sales of

tokens and products to pre-listing investors as business profit, and forms a

virtuous cycle of stabilizing the price by purchasing its own tokens.

The payment options of Cellpinda online stores are existing payment options

such as credit cards, etc. and Cellpinda Points, and during event periods,

Cellpinda Points may be purchased to buy the products.

To convert Cellpidna Tokens for Cellpinda Points, the token holders can

request for exchange via Cellpinda Wallet Web or Application, and link the

wallet with Cellpinda online store to purchase the products.

23

[Cellpinda Token’s Token Economy]

3.4 Eco-system

Cellpinda forms a virtuous cycle of purchasing and spreading products by app

unification of online stores, token wallet, and stress diary. It accumulates the

history of customers’ visits, purchases, product reviews, stress status, and share

histories, and uses it to induce purchases and create periodical or continuous

purchases. It also induces spread of app and product via sharing them on social

media, and by rewarding and accumulating points, provides payment

environment and benefit when purchasing products via online/offline channels.

24

PC Web / Mobile Web Smart Device

SNS offline Users

Cellpinda App Wallet Online

Point Share

Token / Point

Point Cellpinda Product

Rewarding (Revisit/Purchasing)

Rewarding (Activities)

Purchasing By Point

Point

Suggestion Analysis

Eco System

3.5 Cellpinda App

The stress reliever markets’ demand is increasing due to the increase of

stresses in daily lives. However the supply of mental health care apps lacks

compared to physical health care apps. With such background, Cellpinda is

developing a life-friendly app that checks the stress of everyday life of the user

and suggests a solution by Cellpinda products, and is planning to provide

customer management with integration of smart watches.

25

The main function of the application would be ①Checking Stress Status,

②Check Stress Test Results ③Find Cellpinda Stores Nearby, ④Check Product

Purchase History, ⑤Purchase Product, ⑥Request Subscription, etc., and as

subsidiary functions, there would be ①Gift Points, ②Share Contents,

③Participate Events, etc.

Stress diary analyzes the user’s heartbeat, body temperature, etc. the smart

watch collected, checks the stress of the user automatically, and suggests

GABA100 based on the stress. Also, by sensing the movement of the user

during sleep to examine the quality of sleep and suggest Sweat Dreams

(the sleeping disorder improvement product).

It calculates the product consumption date by the date of the product

purchase to suggest the date of the next purchase, and for those who

purchased products, the application notifies the user when to take the

products in the morning, noon, and dinner time, the periodical times to take

products and extra where needed based on the status of the user.

For daily lives, the application checks the health of the users via questions,

periodically with entertaining content, and rewards the users with points for

consuming the contents. In addition, the application rewards the users with

additional points for sharing entertaining contents, information of new

products, and their current status.

Stress Diary App is linked with Cellpinda Online Store and Cellpinda Wallet,

which allows the users to purchase products with the application and right

reviews. On periodical events, the prize winners are given with various rewards,

such as product sample coupons, points, and offers.

With abovementioned functions, the application takes a major role of

Cellpinda ecosystem by intervening with the lives of the users to induce the

purchase of Cellpinda products and spread products via shares and rewards.

Moreover, if enough user data is accumulated, it will contribute to relieving

stress of the overall users with the exposure of stress statistics and composition

of stress distribution map by age, gender, or region.

26

3.6 Cellpinda Online mall

Cellpinda Online Stores are responsive web that displays its components

appropriate to PC and Mobile environments based on the resolution of the display,

thus it can be used on PC and Mobile devices. It will be available as an online store

menu within the official Cellpinda company website, and includes the introduction

of Company, News & Info. The use of the online store is based on sign-up and sign-

in, and contains menus like Customer, and My Office. The product currently being

sold on the online store is hangover cure S’tei, and the products like GABA100,

Sweet Dreams, XL would be progressively added on the store.

*https://cellpinda.com/

[ PC Web ] [Mobile Web ]

27

3.7 Cellpinda Token Wallet

The major functions of Cellpinda Token Wallet are purchasing Cellpinda

Token using Ethereum, and exchanging Cellpinda Token for Cellpinda Points.

It has enhanced security and hacking prevention with captcha authentication

and mobile authentication upon signing in. On the main display of the wallet,

the Cellpinda token purchase history and exchange history of Cellpinda Token

for Cellpinda Point can be browsed.

Also, it provides QR code and wallet address for transferring Ethereum to

Cellpinda Wallet from an exchange, and the price of the Ethereum can be

browsed with data collected from Coingecko every 3 hours.

The web version of Cellpinda Wallet is currently online, and the portion of user

interface is currently being improved for mobile applications.

28

[Cellpinda Token Wallet Mobile app / web (app.cellpinda.com) ]

3.8 Token Sales Reporting System

Self-reporting program is being operated for Cellpinda tokens in relation to

exchange and usage of points, calculating sales, and business profits.

The following major functions of token sales reporting system would be

developed, and it will submit sales reporting result to the competent tax office.

29

3.9 Blockchain

Cellpinda Token is a cryptocurrency issued by the blockchain that uses

Byzantine Fault Tolerance algorithm. BFT is used for the third generation

cryptocurrencies, like Tendermint, Neo, etc., IBM’s Hyperledge selected by VISA,

and R3 Foundation’s CORDA, and it guarantees fast procession speed.

Cellpinda’s blockchain can handle over 1,000 transactions per second (1,000

TPS), which is 142 times faster than Bit Token and 40 times faster than

Ethereum, making it very useful for real economy like making payments. The

business decision on launching main-net will be made based on the number of

presale tokens, and if the mainnet is launched, the blockchain will have

cheaper transaction fee than Ethereum, and fast transaction speed

30

3.10 Distribution

For those who purchased tokens before the listing, lock-up is proceeded for

one month after the listing on the cryptocurrency, and Cellpinda provides 3%

of the amount of tokens the investors own as the lock-up reward.

Reserve 50%

Team 15%

Founder 5%

Marketing 10%

10,000,000,000 CPP

Sale 20%

31

4. Policy 4.1 Risk and Uncertainty

This white paper is a Cellpinda’s business plan, and is not a guarantee for the

business, thus the investors must understand that the actual procession of business

is subject to the business or operational environment.

4.2 STO Participants

The residents of nations that prohibited STO by law cannot participate STO of

Cellpinda Token. If the resident of nations that prohibited STO by law participated

the investment, all legal responsibilities are solely on the investor.

4.3 Usage of Token

We announce that Cellpinda Token cannot be used for any other purposes other

than stated in this white paper, and if an investor used Cellpinda Token for other

purposes, it is out of the scope of Cellpinda’s policy, thus not the company’s

responsibility.

4.4 Cancellation and Refunds

Investment made on Cellpinda Token cannot be cancelled or refunded, thus

requires careful investment.

4.5 Withdrawal limit

Cellpinda tokens are deposited in the wallet as soon as purchasing it, and the

investment thus allowing the investors to browse the investment history; however

the withdrawal of Cellpinda tokens is systemically limited until 30 days after being

listed on the exchanges to limit the trades between individuals.

4.6 Lock-Up

For those who purchased tokens before the listing, lock-up is proceeded for one

month after the listing on the cryptocurrency, and Cellpinda provides 3% of the

amount of tokens the investors own as the lock-up reward.

32

33

5. Team & Advisor 5.1 Team

CEO & Founder Deokhyeon, Jeong

CEO, battery manufacturer, Frebi Lab (Director of KAiREX, the Currency Exchange) EBAY Korea local partner MP3 maker Unique Max CEO NESPOV Director, WONJIN Dermatology CS 2 Director ▶ Over 20 years trade in 21 countries, delivery of more than 700 brands, Global online marketing / home shopping practice, career experience of military welfare department

CSO / Strategic Planner Gyungdo, Kim

Cryptocurrency Exchange KAiREX CX Director Business Planning Consulting Firm, FRUM Chief Consultant An online marketing agent, INPIX Group Head

▶ Hyundai Motor, Samsung Electronics, LG Electronics, Lotte Department Store,. Service, marketing, business planning consulting

CTO / Platform Developer Chungrea, Kim

E-bidding information system production company ITS CEO Global Distributor Curation Global, Director General Manager of ERP System, Vendors' BV, Distribution ▶ Distribution ERP system development, sales computerization system, Numerous experience in development of electronic bidding information system

34

5. Team & Advisor 5.2 Advisor & Partners 5.2.1 Advisor

5.2.2 Partners

Global Financial Coin / Mining

Blockchain Labs

BHP(Bank of Hash Power) Lenlenmine.com

UCG Group (US) Blockchain Qualia

Cryptocurrency Exchange

Legal Advice

KAIREX CEO John.Kim

Sojong Law firm Former executive director

Yoo Sik

셀핀다 웹사이트 https://cellpinda.com 셀핀다 토큰 웹사이트 coin.cellpinda.com

회사주소: 서울특별시 영등포구 여의대방로 65길 6 센터빌딩 13F

대표이사: 정덕현 사업자번호: 575-81-00992 이메일: me@cellpinda.com